Predicted morbidity and mortality in major gastroenterological surgery Asgaut Viste Editorial 15 October 2011 Pages: 1 - 2
The potential value of bursectomy in operations for trans-serosal gastric adenocarcinoma Scott A. Hundahl Editorial 13 December 2011 Pages: 3 - 4
Screening and minimally invasive treatment for gastric cancer are important challenges in elderly patients Osamu Hosokawa Editorial 03 December 2011 Pages: 5 - 6
Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in gastric carcinoma surgery Yoshio HagaYasuo WadaOsamu Kimura Original article 03 May 2011 Pages: 7 - 14
Bacteremia and endotoxemia after endoscopic submucosal dissection for gastric neoplasia: pilot study Masayuki KatoMitsuru KaiseHisao Tajiri Original article 11 May 2011 Pages: 15 - 20
First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer Satoru IwasaTakako Eguchi NakajimaYasuhiro Shimada Original article 15 May 2011 Pages: 21 - 26
Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer Hiroaki SaitoTomohiro OsakiMasahide Ikeguchi Original article 31 May 2011 Pages: 27 - 33
Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery Takanobu YamadaTsutomu HayashiAkira Tsuburaya Original article 15 May 2011 Pages: 34 - 41
Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial Junya FujitaYukinori KurokawaYuichiro Doki Original article 15 May 2011 Pages: 42 - 48
A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer Jen-Shi ChenYen-Yang ChenHung-Ming Wang Original article 08 June 2011 Pages: 49 - 55
Gastric linitis plastica: which role for surgical resection? Corrado PedrazzaniDaniele MarrelliFranco Roviello Original Article 30 June 2011 Pages: 56 - 60
Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer Seiji SatohHiroshi OkabeYoshiharu Sakai Original article 11 June 2011 Pages: 61 - 69
Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older Nobutsugu AbeTakuji GotodaShinichi Takahashi Original article 11 June 2011 Pages: 70 - 75
Safety and feasibility of S-1 adjuvant chemotherapy for gastric cancer in elderly patients Toru AoyamaTakaki YoshikawaAkira Tsuburaya Original article 30 June 2011 Pages: 76 - 82
Clinical features and predictive factors of coagulation syndrome after endoscopic submucosal dissection for early gastric neoplasm Hyuk LeeKyung Seok CheoiYong Chan Lee Original article 15 July 2011 Pages: 83 - 90
Discrepancies in histologic diagnoses of early gastric cancer between biopsy and endoscopic mucosal resection specimens Madoka TakaoNaomi KakushimaHiroyuki Ono Original article 04 August 2011 Pages: 91 - 96
Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study Yoji SanomuraShiro OkaKazuaki Chayama Original article 23 July 2011 Pages: 97 - 105
Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience Paolo PiacentiniEmilia DuranteAndrea Bonetti Short communication 17 August 2011 Pages: 106 - 110
Delayed perforation occurring after endoscopic submucosal dissection for early gastric cancer Kenji IkezawaTomoki MichidaKazuhiro Katayama Case report 23 September 2011 Pages: 111 - 114
